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Supplemental Information
EXTENDED EXPERIMENTAL PROCEDURES
Generation of Crfr2a-eGFPCre BAC Transgenic Mice
Amouse bacterial artificial chromosome (BAC clone RP23-78P13) containing the entire Crfr2 gene was treated as follows to prepare
it for the generation of transgenic mice. First, RecA-mediated homologous recombination (Yang et al., 1997) was used to disrupt
expression of Inmt, a gene present on the BAC and known to be expressed in the brain; this step was taken to prevent a gain-of-
function phenotype that could arise when a gene is overexpressed by a multicopy transgene. Disruption of Inmt was accomplished
by inserting a bovine growth hormone polyadenylation sequence (BGHpA) cassette into the 50 end of the Inmt gene that removed the
start codon; 50 and 30 homologous sequences (referred to as Box A and Box B, respectively) were amplified by PCR (Phusion DNA
polymerase, New England Biolabs) and cloned into pBluescript (Stratagene) flanking the BGHpA cassette. Sequences used were as
follows: Box A (nucleotides 698 to +9, relative to 50 end of Inmt exon I: forward primer, 50-GATCTCTGGTCCTCCTACTTCC-30;
reverse primer, 50-AATTCTAGCCAGCCCACACAGCT-30; Box B (nucleotides +10 to +790): forward primer, 50-AGGGCAAGGTATA
CATAGGAG-30; reverse primer, 50-AGTTCCTTGGCACCGAATGTCTGG-30. The Inmtmutant version of the BAC was then subjected
to a second round of recombineering to target the Crfr2 gene, for which two splice variants have been described in rodents: 1) a
broadly expressed variant that is not highly expressed in brain (Crfr2b, ATG in exon I), and 2) a neuronally expressed form that is
enriched in the brain and present at high levels in LS (Crfr2a, ATG in exon III) (Lovenberg et al., 1995; Chen et al., 2005). To simulta-
neously target Crfr2a and suppress expression Crfr2b from the BAC, two features were incorporated into the targeting vector: 1) a
cassette containing an eGFPCre fusion gene followed by an SV40pAwas inserted into the 50UTR of the third exon of theCrfr2 gene; 2)
a STOP codon was introduced into exon IV (shared by both a and b splice forms) to terminate translation of any Crfr2bmRNA tran-
scribed from the BAC. Sequences used were as follows: Box A (nucleotides532 to +132, relative to 50 end ofCrfr2 exon III: forward
primer, 50-TTCCTAGATGTCCTCCTCTCACC-30; reverse primer, 50-CCCCGGAGCCGCGCG; Box B (nucleotides +149 to +790):
forward primer, 50-CGGCGCTGCTCCTCAGCCTGC-30; reverse primer, 50-ACTTCAACAAACAGCGTAGAGGAAGG-30. The final re-
combineered BAC containing the desired modifications was linearized with NotI, purified away from smaller fragments released
by digestion (vector backbone plus genomic sequences located more than 85 kb upstream of the Crfr2a ATG) using a Sepharose
CL4b column, integrity confirmed by pulsed field gel electrophoresis, and then microinjected into the pronuclei of FVB/N embryos
to generate transgenic mice.
Animal Maintenance
The Crfr2a-eGFPCre BAC transgene was maintained on an FVB/N (Taconic) background. For all behavior experiments, hemizygous
transgenic FVB/N males were bred to C57BL/6N (Harlan Sprague Dawley) females, and FVBB6F1 male mice were used for testing.
All animals were housed at 23Cwith ad libitum access to food andwater in a 13-h day/11-h night cycle, with the day starting at 21:00.
All behavioral testing was done during the dark cycle, starting no earlier than 11:00 and no later than 20:00. Following surgery, mice
were singly housed prior to behavioral testing. We note that quantitative differences in behavioral results might be obtained on an
inbred C57BL/6 congenic background. All experiments were conducted in accordance with NIH guidelines and approved by the
Caltech Institutional Animal Care and Use Committee.
In Situ Hybridization
Single color ISH for Crfr2 was performed on 120 mm thick free floating sections as described previously (Mongeau et al., 2003). In
brief, brains were collected, cut in 3–4 mm coronal slabs using a block, and fixed overnight in 4% paraformaldehyde. Next,
120 mm-thick coronal sections were made from the tissue slabs using a vibratome, followed by gentle digestion for 30 min using pro-
teinase K, fixation with 4% paraformaldehyde, and hybridization at 60C overnight with a cRNA digoxigenin-labeled probe against
Crfr2 mRNA. Nonhybridized probe was washed off at 60C and digested with RNase A at 37C for 30 min. Immunohistochemistry
was performed using antidigoxigenin conjugated with alkaline phosphatase (Roche), and development performed with the alkaline
phosphatase substrate NBT/BCIP. Double-label fluorescent ISH (dFISH) protocols have been previously described in detail (Thomp-
son et al., 2008). In brief, dFISH was performed using a variation of the colorimetric protocol. Briefly, riboprobes were labeled with
either digoxigenin-UTP or dinitrophenyl-11-UTP (DNP; Perkin Elmer). A DNP-labeled probe and a DIG-labeled probe were hybridized
simultaneously to 25 mm thick sections. Tyramide signal amplification was performed for each probe individually, using either anti-
DIG-HRP with tyramide-biotin, or anti-DNP-HRP with tyramide-DNP for amplification. Visualization of signal was achieved using
either streptavidin-Alexa Fluor 488 (Invitrogen/Molecular Probes) or anti-DNP-Alexa Fluor 555 (Invitrogen/Molecular Probes), and
imaging performed on an Olympus FluoView-1000 confocal microscope. Regions used for probes are as follows: Cre recombinase,
nucleotides 489-1441 (GenBank: X03453.1); Crfr2, nucleotides 459-1270 (NCBI Reference Sequence: NM_009953.3); Esr1, nucle-
otides 1123-2102 (GenBank: AB560752.1); Gad2, nucleotides 1069-2094 (NCBI Reference Sequence: NM_008078.2); Penk, nucle-
otides 312-1127 (NCBI Reference Sequence: NM_001002927.2); tdTomato, nucleotides 25-639 and 751-1365 (GenBank:
AY678269.1); due to high homology, Cherry ISH was performed using the tdTomato probe.
Immunofluorescent Labeling
For immunostaining of free floating sections, mice were perfused transcardially with 0.9% saline followed by 4% paraformaldehyde
(PFA) in 13PBS. Brains were then removed and postfixed 16 hr at 4C,washed in 13PBS, and embedded in 3% lowmelting agarose
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for vibratome sectioning at 75–100 mm. For immunostaining, sections were blocked in ‘‘NDS block’’ (5% normal donkey serum, 0.1%
Triton X-100 in 13 PBS) for a minimum of 30’ at room temperature, and primary antibodies diluted in NDS block and incubated 16 hr
at 4C. Following this, sections were washed 33 in PBS-T (0.1% Triton X-100 in 13 PBS), and incubated for 1–2 hr at room temper-
ature in fluorescent secondary antibodies (Jackson Immunoresearch) diluted 1:1,000 in PBS-T. After this incubation, sections were
washed, counterstained with 4’,6-diamidino-2-phenylindole (DAPI), mounted, and coverslipped using either ProLong Gold Antifade
Reagent (Invitrogen) or Fluoro Gel (Electron Microscopy Sciences). Cryosection immunostaining was performed similarly, with the
following differences. After perfusion, brains were postfixed in 4% PFA for 1–2 hr on ice, followed by cryoprotection overnight at
4C in 15% sucrose in 13 PBS, embedding in OCT, cryosectioning at 20 mm and collection onto Superfrost Plus slides (Ted Pella).
Prior to immunostaining, sections were washed once in 13 PBS, and then postfixed for 5 min in cold methanol. Immunostaining then
proceeding as detailed above for floating sections. Antibodies used were as follows: rabbit anti-Cre (Covance #PRB-106C *note: the
lot used in this study is no longer available and newer lots have not worked for IHC), goat anti-CTB (List #703), chicken anti-eGFP
(Abcam #ab13970), rabbit anti-ESR1 (Santa Cruz #sc-542), and rabbit anti-UCN3 (Cosmo Bio Co #YII-Y364-EX). Secondary immu-
noreagents were obtained from Jackson Immunoresearch and Invitrogen. Fluorescent nuclear counterstaining was performed using
4’,6-diamidino-2-phenylindole (DAPI).
Cell Counting
DAPI-counterstained sections were imaged on an Olympus FluoView-1000 confocal microscope, and cell counts performed using
MetaMorph (Molecular Devices) in combination with manual scoring to ensure accuracy. Details on the specific regions quantitated
are given in the relevant figure legends.
Cre-Dependent Viral Vectors
Viral plasmids encoding Cre-dependent opsins were provided by the Deisseroth (AAV-EF1a-DIO-hChR2(H134R)-EYFP, AAV-EF1a-
DIO-eNpHR2.0-EYFP) and Boyden (AAV-CAGD-ArchT-GFP-FLEx) laboratories and packaged in serotype AAV5 at the University of
Pennsylvania (U Penn) Gene Therapy Vector Core (ChR2-YFP and ArchT-GFP) or Harvard Gene Therapy Initiative (HGTI, eNpHR2.0-
YFP). AAV5 encoding Cre-dependent ChR2-tdTomato was purchased from U Penn Vector Core inventory (lot #V1345). Cre-
dependent AAV plasmid expressing humanized renilla GFP (hrGFP) was a gift from Clif Saper and was packaged in AAV5 at
HGTI. Cre-dependent AAV5 expressing eYFP was purchased from the University of North Carolina (UNC) Gene Therapy Department
stock inventory (AAV-EF1a-DIO-EYFP). AAV5 containing a CMV-Cre cassette was purchased from Vector Biolabs. A Cre-dependent
nuclear-localizedmCherry construct was generated by fusing a 3x nuclear localization sequence tomCherry and cloning this in place
of ChR2-YFP in the vector EF1a-DIO-hChR2(H134R)-EYFP; packaging of this construct in AAV5 was done at U Penn. Construction,
packaging, and validation of the Cre-dependent HSV129 variant HSV129DTK-TT has been previously described (Lo and Anderson,
2011). HSV129DTK-TT anterograde spread and labeling (tdT) are initiated only in Cre+ ‘‘starter’’ cells; once rendered replication-
competent in starter cells, the virus is able to propagate in the anterograde direction through downstream nodes of a given circuit.
Electrophysiological Slice Recordings
Standard mouse brain slice preparation and whole-cell recording were performed as follows: 3-5 month old mice were euthanized
and coronal brain sections 250 mm thick were cut on a Vibratome (VT1000S; Leica) in ice-cold glycerol-based artificial cerebrospinal
fluid (composition in mM: 252 glycerol, 1.6 KCl, 1.2 NaH2PO4, 1.2 MgCl2, 2.4 CaCl2, 18 NaHCO3, 11 glucose, oxygenated with 95%
O2/5% CO2). Slices were allowed to recover for 90 min at 32
C in standard artificial cerebrospinal fluid (ACSF; composition in mM:
126 NaCl, 1.6 KCl, 1.2 NaH2PO4, 1.2 MgCl2, 2.4 CaCl2, 18 NaHCO3, 11 glucose, oxygenated with 95%O2/5%CO2). After this recov-
ery period, slices were then transferred to room temperature oxygenated ACSF where they remained until recording. Cells express-
ing GFP or YFP were detected by infrared differential interference contrast (IR-DIC) and fluorescence video microscopy (Olympus
BX51). Whole-cell voltage and current clamp recordings were performed at 30C with a MultiClamp 700B amplifier and Digidata
1440A (Molecular Devices). The patch pipette, with a resistance of 7–9 MU,was filled with an intracellular solution containing
(inmM) 135 potassium gluconate, 5 EGTA, 0.5 CaCl2,2MgCl2, 10 HEPES, 2MgATP and 0.1GTP, pH7.2, 280–300mosM. Series resis-
tance was typically 20–30 MU. Cell attached recordings were performed in voltage clamp with holding current maintained at zero,
and using pipettes filled with ACSF. Appropriate bridge balance was applied to all current clamp recordings. Data were sampled
at 10 kHz, filtered at 3 kHz and analyzed with pCLAMP10 or Igor Pro (Wavemetrics) using the Neuromatic analysis software package
written by Jason Rothman (http://neuromatic.thinkrandom.com/).
Stereotaxic Surgery
Mice 2–5 months old were anaesthetized 2.5% isoflurane, placed into a stereotaxic frame (Kopf Model 940), and anesthesia main-
tained using 1%–1.5% isoflurane. To enhance uptake of pressure injected solutions, animals were injected with 0.4 ml of 20%
mannitol (Phoenix Pharmaceuticals). The skull was exposed and holes produced using with a hand-held drill (Roboz) with 0.7mm
bits (Fine Science Tools). Injections were targeted using coordinates based on the Paxinos and Franklin mouse brain atlas (Paxinos
and Franklin, 2001), relative to bregma (LS, AP+0.5, ML ± 0.59,DV-2.8; AHA, AP-0.8, ML ± 0.3, DV-4.9; LH, AP-1.6, ML ± 0.9, DV-
5.25). Virus was backfilled into glass capillaries (tip diameter 50 mm) and delivered at a rate of 30 nl per minute using a nanoliter
injector (Nanoliter 2000, World Precision Instruments) controlled by an ultra microsyringe pump (Micro4, World Precision
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Instruments). Volumes delivered were between 50–100 nl, amounts determined empirically to be the largest that would label cells in
LS without spread to and recombination in adjacent brain regions. AAV molecular titers were on the order of 3E+12, resulting in a
total 3E+8 total viral particles delivered per injection site. If needed, bilateral stainless steel guide cannulas (Plastics1) were
implanted above the injection sites; lengths of tubing below pedestal were: LS, 2.6 mm; AHA, 4.2 mm. After implantation, bilateral
stylets were inserted into the guides to prevent clogging. For optogenetic manipulations of LS Crfr2a+ axons in the hypothalamus,
bilateral stainless steel guide cannulas were implanted with tips located 1.5 mm posterior and 1.5 mm ventral to the virus injection
sites in LS and which extended down to approximately 500 mm above the medial hypothalamus at the level of the AHA. For postop-
erative care, mice were injected subcutaneously with ketoprofen (2 mg per kg body weight) and supplied for 7 days with drinking
water containing 400 mg/l sulphamethoxazole and 200 mg/l ibuprofen. Mice were given four (eNpHR2.0 and ArchT) or six (ChR2)
weeks after injection to allow for viral expression before being used for behavior experiments. All surgically manipulated animals
underwent histological examination to ensure proper guide placement and/or that viral expression was restricted to the LS.
In Vivo Optogenetic Control of Neuronal Activity
To enable in vivo delivery of light, custom bilateral fiber assemblies were built by inserting two 200 mm optic fibers (0.37 NA multi-
mode fiber, Thorlabs) through plastic bilateral guide pedestals (from which the steel tubing had been removed), gluing them in
place, and then cutting the ends so that the tips of the fibers would be flush with the tips of implanted stainless steel guides in
the brains of mice. On the day of testing, mice were anesthetized with isoflurane, stylets were removed and a bilateral fiber assem-
bly was connected by inserting one end into the guide (held in place using dust caps (Plastics1)) and the other end connected via
FC/PC to a 1 3 2 intensity division fiber optic rotary joint (Doric Lenses) that was suspended above the test arenas using a boom
microphone stand (Proline). Two mice were tested at the same time by connecting two rotary joints to a beam splitter (1 3 2
intensity division minicube, Doric Lenses) that was in turn connected to lasers (473 nm, 532 nm, or 59 nm, Shanghai Laser & Optics
Century) located outside the testing room and which were controlled by a pulse stimulator (A310 Accupulser Signal Generator,
World Precision Instruments). Light power at the tips of the fibers were measured prior to insertion into mice using a power meter
(Thorlabs).
Behavioral Testing
All behavioral testingwas done usingmaleCrfr2a-eGFPCremice on an FVBB6F1 background. Animals were lightly anesthetizedwith
2% isoflurane prior to testing to allow insertion of fiber optic cables, which was done in the antechamber of the room where the
animals were housed. To assay anxiety behavior, mice were tested sequentially in three standard assays, each lasting 10 min
each: light-dark box (LDB), box dimensions 50 3 25 3 30 cm; light side 31 cm long, dark side 16 cm long; doorway between light
and dark sides, 5.25 cm wide, 9 cm high), mice introduced into dark side at start of assay, parameters measured included number
of entries into and time spent in light side; open field (OF), 503 503 30 boxes constructed from white 1/8’’ ABS white plastic, mice
introduced into a corner at start of assay, parameters measured included number of entries into and time spent in a 17 3 17 cm
square region in the ‘‘center’’ of the open field, total distance moved, and time spent immobile; novel object (NO), a stainless steel
cup (base diameter 3.5 cm, lip diameter 5.75 cm, base to lip height = 4.5 cm) was placed in the center of the open field box, param-
eters measured included number of entries into and time spent exploring the object in a 173 17 cm square region in the ‘‘center’’ of
the open field, total distance moved, and time spent immobile. Average velocity in the open field was calculated by dividing total dis-
tance moved by time spent mobile (Distance moved / Time in OF – time spent immobile). To avoid confounds from conditioning
effects (i.e., conditioned fear instead of innate anxiety), separate groups ofmicewere injected and tested for each data set presented.
The one exception to this is the data in Figure S2H (retesting ChR2-injectedmice 7 days after stimulation); in that experiment, different
novel objects were used in the second assay (6 3 6 3 1.25 cm plastic squares). For photoinhibition experiments involving stress,
mice were subjected to 20min of immobilization stress, an length of time determined empirically to be theminimum length necessary
to elevate anxiety in FVBB6F1 mice (data not shown). Note that no differences were detected between groups in that experiment. All
behavior experiments were captured in MPEG-2 (.m2v) format using Mediacruise (Canopus) and analyzed with Ethovision 3.1
(Noldus Information Technology). At the completion of behavioral testing, all mice were perfused and histologically analyzed to
ensure viral expression was restricted to LS and guide cannulas were properly positioned. Procedures used for individual experi-
ments were as follows:
Photostimulation of LS Crfr2a+ Cells Using ChR2(H134R)-YFP during Testing in Naive Mice
Following insertion of optic fibers into guides, mice were placed in a new cage, transferred to the testing room and connected to a
1 3 2 rotary joint. After a 10 min period to recover from anesthesia, mice were run sequentially through the LDB, OF, and NO
(10 min each assay) in the presence of 473 nm light (15 Hz, 20 ms pulse width, 5 s ON, 5 s off). For all ChR2 experiments, light
power at the fiber tips was 380 mW/mm2, which is sufficient to yield 1 mW/mm2 (the minimum amount of light reported to be
capable of efficient ChR2 activation; Aravanis et al., 2007) at 1.4 mm below the fiber tips and therefore should be capable of pho-
tostimulating the full dorsoventral span of LS Crfr2a+ cell bodies.
Photostimulation of LS Crfr2a+ Cells Using ChR2(H134R)-YFP prior to Testing in Naive Mice
Following insertion of optic fibers into guides, mice were transferred to a novel ‘‘stimulation’’ room and placed in a clean cage inside
an open box that had been sprayed with a novel odor (Simple Green). After connection to a 1 3 2 rotary joint, mice received photo-
stimulation with 473 nm light (15 Hz, 20 ms pulse width, 5 s ON, 5 s off) for 30 min. Following this, photostimulation was terminated,
Cell 156, 522–536, January 30, 2014 ª2014 Elsevier Inc. S3
optic fibers were removed, and stylets reinserted into the guides. All animals were thenmoved out of the stimulation room and into the
testing room, and run through the anxiety test battery (LDB,OF,NO) as described above.
Photostimulation of LS Crfr2a+ Cells Using ChR2(H134R)-YFP during Stress prior to Testing
To minimize the potential confound of a ceiling effect (i.e., anxiety levels so high that no additional elevation is detectable in these
assays), mice used for this experiment were habituated by handling 5 min per day for 3 days prior to testing in order to reduce sensi-
tivity to stress. Following insertion of optic fibers into guides, mice were subjected to immobilization stress (IMS) by taping their limbs
to a plastic tray using green lab tape (VWR); taping required 30 s and was completed just as mice were awaking from isoflurane
anesthesia. IMS was done in a biosafety cabinet for 30 min during which time mice received photostimulation with 473 nm light
(15 Hz, 20 ms pulse width, 5 s ON, 5 s off). Following this 30 min period, optic fibers were removed, mice were released from
IMS, and then transferred in a new cage to the testing room where they were then run through the anxiety test battery (LDB,OF,NO)
as described above.
Photoinhibition of LS Crfr2a+ Cells Using eNpHR2.0-YFP during Stress prior to Testing
Following insertion of optic fibers into guides, mice were subjected to immobilization stress (IMS) in a biosafety cabinet for 20 min
during which time they received illumination with 593 nm light (continuous light, 20 s ON, 10 s off). In all eNpHR2.0 experiments, light
power at the fiber tips was 475mW/mm2. Following this 20min period, optic fibers were removed, mice were released from IMS, and
were then transferred in a new cage to the testing room where they were then run through the anxiety test battery (LDB,OF,NO) as
described above.
Photoinhibition of LS Crfr2a+ Cells Using eNpHR2.0-YFP after Stress during Testing
Following insertion of optic fibers into guides, mice were subjected to immobilization stress (IMS) in a biosafety cabinet for 20 min.
Following this 20 min period, mice were released from IMS and transferred in a new cage to the testing room. Fibers were connected
to a 13 2 rotary joint, andmicewere run through the anxiety test battery (LDB,OF,NO) as described abovewhile receiving illumination
with 593 nm light (continuous light, 20 s ON, 10 s off) throughout testing.
Photoinhibition of LS Crfr2a+ Cells Using eNpHR2.0-YFP during Testing in Naive Mice
Following insertion of optic fibers into guides, micewere transferred in a new cage to the testing room and connected to a 13 2 rotary
joint. After a 10 min period to recover from anesthesia, mice were run sequentially through the LDB, OF, and NO, mice were run
through the anxiety test battery (LDB,OF,NO) while receiving illumination with 593 nm light (continuous light, 20 s ON, 10 s off)
throughout testing.
Photoinhibition of LS Crfr2a+ Projections to AHA Using ArchT-GFP after Stress during Testing
Following insertion of optic fibers into guides, mice were subjected to IMS in a biosafety cabinet for 20 min. Following this 20 min
period, mice were released from IMS and transferred in a new cage to the testing room. Fibers were connected to a 13 2 rotary joint,
and mice were run through the anxiety test battery (LDB,OF,NO) as described above while receiving illumination with 532 nm light
(continuous light, 20 s ON, 10 s off) throughout testing. Light power at the fiber tips was 318 mW/mm2.
Photostimulation of LS Crfr2a+ Terminals in AHA Using ChR2(H134R)-YFP during Testing in Naive Mice
Following insertion of optic fibers into guides, mice were placed in a new cage, transferred to the testing room, and connected to a
1 3 2 rotary joint. After a 10 min period to recover from anesthesia, mice were run sequentially through the LDB, OF, and NO
(10 min each assay) in the presence of 473 nm light (15 Hz, 20 ms pulse width, 5 s ON, 5 s off).
Statistics
Responses to stress can vary widely, with some individuals showing robust and persistent elevations in anxiety behavior while others
are relatively resilient and maintain normal functioning even following exposure to severe trauma (Russo et al., 2012). We observed
largevariations in susceptibility to immobilization stressamong themice tested, including thepresenceof resilient outliers that resulted
in data sets that were nonnormally distributed (i.e., failed three different tests for normality: Kolmogorov-Smirnov, D’Agostino and
Pearson omnibus normality test, and Shapiro-Wilk normality tests). For this reason, all data derived from stressed mice were plotted
in box andwhisker format (withwhiskers representingminimumandmaximumdata points) and statistical significance assessedusing
nonparametric Mann-Whitney U tests. In contrast, data from unstressed mice generally passed at least one of the tests for normality
and so were plotted as standard column bar graphs depicting mean ± SEM and analyzed for significance using unpaired t tests.
Channelrhodopsin-Assisted Circuit Mapping
Four to six weeks after injecting Cre-dependent ChR2(H134R)-YFP AAV5 into LS, brain slices were prepared for electrophysiological
recordings as described above. Light from a 473 nm laser (Shanghai Dream Laser) was delivered via a 200 mm fiber optic cable
positioned next to the region of interest using a micromanipulator. Light pulses (2 ms pulse width) were triggered using pClamp;
synchronouswith the triggering of the laser, a 200 ms depolarization of 1mVwas done to create an artifact that enabled determination
of the precise time when the light pulse was initiated. Cells in whole-cell configuration were held in voltage clamp at 40 mV and
identification of currents as being GABA-A-mediated was done using 100 mM picrotoxin. No postsynaptic excitatory currents
were detected in response to stimulation of LS Crfr2a+ neurons (0/66 cells). Onset of postsynaptic responses was determined using
the Threshold method (Fedchyshyn and Wang, 2007), where IPSC onset was defined at the time point when the response reached
10%of its maximum. Latency to onset of a response was determined by subtracting the time point when the laser was triggered from
the time point when onset of a PSC occurred.
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Retrograde Tracing
For neuroanatomical studies using CTB, mice were prepared for stereotaxic surgery and CTB (0.5% in PBS, List) was iontophoret-
ically delivered using alternating positive current (5 mA, 7 sON, 7 sOFF) for 3min using aMidgard Precision Current source (Stoelting).
Following survival times of 5–7 days, mice were perfused and processed for immunostaining. For experiments involving CRACM
combined with retrograde tracing, Cre-dependent ChR2-YFP AAV was injected into the LS of Crfr2a-eGFPCre mice. Following a
4 week viral incubation period, 20 nl of red retrobeads (diluted 1:4) were injected into the PVN (AP-0.4, ML+0.25, DV-4.5 to 4.4),
and recordings performed 5 or 14 days later.
Corticosterone Measurements
Mice were injected and implanted as described above. To test effects of Crfr2a+ neuronal stimulation in naive mice on circulating
corticosterone levels,Crfr2a-eGFPCre male mice injected and implanted in LS with Cre-dependent ChR2-YFP AAV5 and guide can-
nulas respectively were anesthetized with 2% isoflurane and optic fibers inserted. Mice were transferred to a novel room and placed
in a clean cage inside an open box. After connection to a 13 2 rotary joint, mice received photostimulation with 473 nm light (15 Hz,
20ms pulse width, 5 s ON, 5 s off) for 30 min. Light power at the fiber tips was 380mW/mm2. Following this, photostimulation ceased
and mice were immediately euthanized and decapitated (45–60 s following termination of photostimulation) for blood collection. To
test the role of the LSCrfr2a+ projection to the AHA in stress-induced elevation of corticosterone,Crfr2a-eGFPCremalemice injected
in LS with Cre-dependent ArchT-GFP AAV5 and implanted with guide cannulas over the AHA were anesthetized with 2% isoflurane
and optic fibers inserted. Mice were subjected to IMS in a biosafety cabinet for 20 min during which time they received illumination
with 532 nm light (continuous light, 20 s ON, 10 s off). Light power at the fiber tips was 318 mW/mm2. Following this, illumination
ceased and mice were immediately euthanized and decapitated (45–60 s following termination of illumination) for blood collection.
For both groups, blood was collected in 1.5 ml Eppendorf tubes and allowed to clot at room temperature for 10min. Tubes were then
spun at 2,000 g for 15 min to pellet cells, and supernatant containing clear serum removed and frozen on dry ice. Corticosterone
concentrations were measured using an enzyme immunoassay kit (Cat#900-097, Enzo Life Sciences).
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Figure S1. Additional Characterization of Crfr2 mRNA and BAC Transgene Expression in LS, Related to Figure 2
(A and B) dFISH for Crfr2 (green) versus the glutamatergic marker Slc17a6 (a.k.a. vGlut2, red).
(C) No overlap is observed between Crfr2 and Slc17a6 in LS: Crfr2+/DAPI+ = 8.2%, Slc17a6+/DAPI+ = 1.6%, Crfr2+/Slc17a6+ = 0, Slc17a6+/Crfr2+ = 0;
8.2%x1.6%x11,221 DAPI+ cells counted 15 Crfr2+Slc17a6+ cells expected if expression were random; 0 Crfr2+Slc17a6+ cells were observed.
(D–F) dFISH for Crfr2 (green) versus the cholinergic marker ChAT (red). We detected no ChAT expression in lateral septum, despite observing numerous ChAT+
cells in other regions known to contain cholinergic neurons such as medial septum (MS in D,F), striatum, and basal forebrain (data not shown).
(G–O) Counts of eGFPCre+ cells at three rostrocaudal levels of LS (G-I, bregma+1.0; J-L, bregma+0.6; M-O, bregma+0.2) revealed that, similar to endogenous
Crfr2 mRNA (main Figures 2A–2E), immunodetectable transgene expression is highest at middle LS levels (bregma+0.6), with fewer immunopositive neurons in
more rostral and caudal regions. (I) Bregma+1.0, dorsal LS, eGFPCre+/DAPI+ = 1.3% ± 0.5%, n = 1,527 DAPI+ cells; ventral LS, eGFPCre+/DAPI+ = 0.9% ± 0.6%,
n = 1,828 DAPI+ cells. (L) Bregma+0.6, dorsal LS, eGFPCre+/DAPI+ = 6.8% ± 2.0%, n = 1,932 DAPI+ cells; ventral LS, eGFPCre+/DAPI+ = 11.2% ± 1.8%, n = 2,412
DAPI+ cells. (O) Bregma+0.2, dorsal LS, eGFPCre+/DAPI+ = 0.8% ± 0.3%, n = 1,881 DAPI+ cells; ventral LS, eGFPCre+/DAPI+ = 1.2% ± 0.1%, n = 2,525 DAPI+
cells. Counts are mean ± SEM from 3 separate Crfr2a-eGFPCre transgenic mice.
(P–S) Immunostaining for BAC transgenic eGFPCre (green) andGABA (red), and quantitation; (S) 306/354GFPCre+ cells (86.4%) were GABA+, which is similar the
percentage of Gad2+/Crfr2+ cells detected using dFISH (main Figure 2F).
Finally, we note that in our Channelrhodopsin-assisted circuit mapping (CRACM) experiments in which ChR2 was expressed in LS Crfr2a+ cells and recordings
performed to identify postsynaptic targets, monosynaptic inhibitory postsynaptic currents (IPSCs) were detected in 44/66 cells (15/18 in LS, 29/48 in hypo-
thalamus). However, excitatory postsynaptic currents were never detected (0/66 cells). Taken together, these data demonstrate that Crfr2a+ neurons are a
predominantly GABAergic, inhibitory population.
S6 Cell 156, 522–536, January 30, 2014 ª2014 Elsevier Inc.
(legend on next page)
Cell 156, 522–536, January 30, 2014 ª2014 Elsevier Inc. S7
Figure S2. Injection of Cre-Dependent AAVs Employing the EF1a Promoter into Crfr2a-eGFPCre Mice Yields Specific Expression in Crfr2a+
Neurons, Related to Figure 2
(A) Stereotaxic injection into the LS of Crfr2a-eGFPCre mice of a Cre-dependent AAV5 in which the EF1a promoter drives expression of a nuclear-targeted
mCherry. Recombination is strongest in laterally situated neurons of LSi and LSv, with scattered Cherry+ cells seen in medial LS. This pattern of recombination is
similar to expression of endogenous Crfr2 mRNA (Figure 1C in main text). Volume of AAV injected = 100 nl.
(B) Coinjection of the Cre-dependent Cherry construct together with a second AAV that constitutively expresses Cre recombinase was done to assess the
labeling when recombination occurred in a large fraction of infected cells. In this case, no clear patterning is observed, with Cherry+ cells detected throughout the
LS. Moreover, the amount of Cre-dependent Cherry AAV in this experiment (50 nl) is half the volume injected in experiment shown in (A) and yet results in
significantly more labeling. These data indicate that the pattern of recombination seen in (A) is a reflection of Cre activity and not due to an inability of AAV5 or the
EF1a promoter to infect or express in LS neurons in general.
(C–G) Assessment of the sensitivity and specificity of Cre-dependent AAVs injected into LS of Crfr2a-eGFPCre mice. (C–F) Comparison of transgenically ex-
pressed eGFPCre (green) and virally expressed Cherry (red). Similar to what was observed with endogenous Crhr2 mRNA (inset in Figure 1C of main text), the
Crfr2a-eGFPCre transgene showed a broad dynamic range of expression, driving both low (arrows in C-F) and high (arrowhead in C-F) expression of eGFPCre,
both of which were sufficient to catalyze recombination of the injected AAV. (G) Counts were performed in regions containing Cherry+ cells: eGFPCre+/DAPI+ =
15.1%, Cherry+/DAPI+ = 7.9%, Cherry+/eGFPCre+ = 34.7%, eGFPCre+/Cherry+ = 66.4%; total n = 2,671 DAPI+ cells
(H–K) Two factors complicate efforts to assess the specificity of recombination in transgenic or gene targeted mice that use cell type-specific promoters to
express Cre. First, the ability of Cre to catalyze recombination even when present at very low levels can lead to labeling of cells in which the endogenousmRNA or
protein under the regulation of the cell-specific promoter cannot be detected. This has been observed in gene targeted mouse lines (Madisen et al., 2010; Yizhar
et al., 2011), suggesting it is a reflection of Cre sensitivity. Similarly and in the case ofCrfr2, a second complicating factor is its broad dynamic range of expression
and possibility of failure to detect message in low expressors when using dFISH (i.e., false negatives). We therefore used an indirect approach to further test
specificity of recombination in Crfr2a-eGFPCre mice. We reasoned that if recombination were occurring randomly, it should be detected in LS populations that
are known to be Crfr2-negative. We defined two such populations as those that express Esr1 or Penk (Figures 2G–2J in main text), and so used immunostaining
(H,I) or dFISH (J,K) to determine if any recombination had occurred in Esr1+ (H,I) or Penk+ (J,K) cells. This analysis revealed that significant recombination had
not occurred in either of these two populations; counts were performed in regions containing Cherry+ cells: Cherry versus ESR1: ESR1+/DAPI+ = 3.1%,
Cherry+/DAPI+ = 7.8%, Cherry+/ESR1+ = 0, ESR1+/Cherry+ = 0; 3.1%x7.8%x1,645 cells counted = 4 Cherry+ESR1+ cells expected if recombination were
random, 0 Cherry+ESR1+ cells were observed; Cherry versus Penk: Penk+/DAPI+ = 9.4%; Cherry+/DAPI+ = 7.2%, Cherry+/Penk+ = 0.5%, Penk+/Cherry+ = 0.6%;
9.4%x7.2%x7,187 cells counted = 49 Cherry+/Penk+ cells expected if expression were random; 3 Cherry+Penk+ cells were observed.
(L–O) Absence of significant recombination in ESR1+ and Penk+ cells is not due to the inability of AAV5 or the EF1a promoter to infect or express in these
populations. Coinjection of the Cre-dependent Cherry AAV together with a CMV-Cre AAV resulted in Cherry expression in both ESR1+ (L,M) and Penk+ (N,O) cells
near expected frequencies, counts were performed in regions containing Cherry+ cells. (M) Cherry versus ESR1: ESR1+/DAPI+ = 5.3%, Cherry+/DAPI+ = 25.1%,
Cherry+/ESR1+ = 29.1%, ESR1+Cherry+ = 6.2%; 5.3%x25.1%x2,780 cells counted = 37 Cherry+ESR1+ cells expected if recombination were random,
43 Cherry+ESR1+ cells were observed. (O) Cherry versus Penk: Penk+/DAPI+ = 9.3%, Cherry+/DAPI+ = 27.3%, Cherry+/Penk+ = 36.7%, Penk+Cherry+ = 12.5%;
9.3%x27.3%x5,061 cells counted = 128 Cherry+/Penk+ cells expected if expression were random; 172 Cherry+Penk+ cells were observed.
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Figure S3. LS Crfr2a+ Neuronal Responses to Optogenetic Stimulation and ChR2 Behavior Controls, Related to Figure 3
(A and B) To determine the maximal rates at which LS Crfr2a+ neurons are capable of efficient firing in response to photostimulation, whole-cell recordings were
performed on Crfr2a+ChR2+ cells in acute slices from Crfr2a-eGFPCre mice injected 4 weeks earlier with Cre-dependent ChR2 AAV. (A) Cells (n = 3) were
photostimulated with 473 nm light (20 ms pulses) at three different frequencies (10,15, or 20 Hz) in three sweeps (5 s ON, 5 s OFF). The number of missed spikes
were counted and the fraction of successful action potentials was plotted (A’). Efficient firing was observed in response to photostimulation at 10 and 15 Hz, but
larger numbers of failures occurred at 20 Hz. This suggests 15 Hz as the maximal practical photostimulation rate for Crfr2a+ChR2+ cells, a frequency that also
drove efficient picrotoxin (PTX)-sensitive postsynaptic inhibitory responses in downstream targets (B, B’).
(C) Cell-attached recordings to test the ability of Crfr2a+ChR2+ neurons to be repetitively photostimulated. top, a single 2 ms flash of 473 nm light induced a
rapid current response (latency < 1ms); (C’) Photostimulation at 15Hz (2 ms pulse, 5 s ON) drove repetitive action currents (ACs) that were blocked by TTX.
(C’’) Extended photostimulation (15 Hz, 2 ms pulse, 5 s ON, 5 s OFF for 30 min) drove efficient firing with low failure rates throughout the recording in 5/6 neurons
tested (C’’’).
(D) Stimulating Crfr2a+ neurons during testing increases anxiety in the elevated plus maze. hrGFP(n = 14) versus ChR2(n = 16): entries in open arms (3.1 ± 0.6
versus 1.3 ± 0.4, p < 0.05), time in open arms (28.1 ± 6.0 versus 12.6 ± 3.7, p < 0.05).
(E) Stimulating Crfr2a+ neurons during testing does not alter locomotor behavior. hrGFP(n = 39) versus ChR2(n = 38): Average velocity in the open field when
animals were mobile (14.9 ± 1.3 versus 14.8 ± 0.8, p > 0.9).
(F) ChR2 expression in Crfr2a+ neurons has no behavioral effects in the absence of 473 nm light. hrGFP (n = 12) versus ChR2(n = 12): LDB, entries in light side
(9.0 ± 2.1 versus 9.3 ± 1.3, p > 0.5), time in light side (138.5 ± 42.7 versus 160.0 ± 31.2, p > 0.5); OF, entries in center (18.7 ± 2.4 versus 22.1 ± 3.7, p > 0.4), time in
center (25.6 ± 4.7 versus 31.4 ± 4.4, p > 0.3); NO, entries in center (34.3 ± 3.9 versus 34.7 ± 2.8, p > 0.9), time in center (79.1 ± 13.3 versus 86.7 ± 12.0, p > 0.6).
(G) StimulatingCrfr2a+ neurons does not alter locomotor behavior during subsequent testing. eYFP(n = 13) versus ChR2(n = 12): average velocity in the open field
when animals were mobile (13.0 ± 0.3 versus 12.9 ± 0.4, p > 0.8).
(H) Retesting of mice 1 week after stimulation revealed no significant behavioral differences between groups. eYFP(n = 11) versus ChR2(n = 11): LDB, entries in
light side (20.6 ± 2.7 versus 18.2 ± 1.5, p > 0.4), time in light side (220.7 ± 22.0 versus 257.8 ± 20.7, p > 0.2); OF(0–50), entries in center (9.7 ± 1.0 versus 7.5 ± 1.5,
p > 0.2), time in center (14.0 ± 2.3 versus 9.7 ± 1.9, p > 0.15); NO(0–50), entries in center (12.0 ± 2.3 versus 9.0 ± 2.3, p > 0.35), time in center (22.3 ± 7.7 versus
18.5 ± 5.7, p > 0.65).
(I) Photostimulation of LSCrfr2a+ neurons at 1 Hz is not sufficient to induce a persistent anxious state. eYFP(n = 13) versus ChR2(n = 14): LDB, entries in light side
(7.2 ± 1.8 versus 4.5 ± 1.1, p > 0.2), time in light side (74.8 ± 23.6 versus 44.9 ± 13.6, p > 0.25); OF(0–50), entries in center (7.2 ± 1.4 versus 4.5 ± 1.3, p > 0.15), time
in center (7.2 ± 1.4 versus 5.5 ± 1.5, p > 0.4); NO(0–50), entries in center (12.9 ± 3.4 versus 6.9 ± 2.5, p > 0.15), time in center (27.4 ± 7.6 versus 11.3 ± 6.3, p > 0.10).
Values in (D)–(I) indicate mean ± SEM.
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Figure S4. Photoinhibition of LS Crfr2a+ Neurons and Controls for eNpHR2.0 Behavior Experiments, Related to Figure 4
(A–C) Whole cell voltage (A) or current (B) clamp recordings of eNpHR-YFP+Crfr2a+ neurons in response to 593 nm light (yellow lines) in LS slice preparations.
(C) 59 nm light drove (left) outward currents (peak = 47.5 ± 14.6 pA; steady state = 19.2 ± 5.2 pA) and (right) hyperpolarization (peak = 21.8 ± 4.4 mV; steady
state = 10.9 ± 2.4 mV) of moderate amplitudes. Values indicate mean ± SEM; n = 8 eNpHR-YFP+ neurons recorded.
(D) To test whether repeated cycles of photoinhibition might lead to rebound firing (i.e., following hyperpolarization, membrane potential briefly rebounds to a
more depolarized level than that prior to hyperpolarization, resulting in a transient increase in firing rate),Crfr2a+eNpHR-YFP+ neurons in whole-cell current clamp
recording configurationwere subjected to 40 sweeps of the following light protocol: 5 s light off, 20 s light ON, 5 s light OFF (left). In 3/3 cells, no significant rebound
firing was observed, even after 20 min of repeated photoinhibition (right). Brief current injections performed at the completion of each sweep confirmed that the
cells were healthy and capable of firing action potentials (data not shown).
(E) InhibitingCrfr2a+ neurons during IMS does not alter locomotor behavior during subsequent testing in the open field. hrGFP(n = 15) versus eNpHR (n = 17), data
presented Mann-Whitney U value, P value: (U = 116.0, p > 0.65).
(F) Inhibiting Crfr2a+ neurons during testing does not alter locomotor behavior in the open field. hrGFP(n = 11) versus eNpHR (n = 11), data presented Mann-
Whitney U value, P value: (U = 46.5, p > 0.8).
(G) To test if low anxiety behavior might be more prevalent during light ON periods, we pooled together animals that received photoinhibition during testing which
were injectedwith either eNpHR (cell body inhibition, Figure 4L) or ArchT (axon terminal inhibition, Figure 6E) and counted the number of entriesmade into the light
side of the light-dark box during light OFF periods versus the first 10 s of light-ON periods. Due to small group sizes, eNpHR- or ArchT-injectedmice alone yielded
trends but not significant increases in low anxiety behavior during light ON periods (data not shown). In contrast, pooling both groups of mice together revealed a
significant increase in entries made during light ON periods, indicating that the anxiolytic effects observed in response to optogenetic inhibition of Crfr2a+ cell
bodies or axons are not due to rebound effects during light OFF periods (n = 17), Wilcoxon matched-pairs signed rank test (p < 0.05). No significant difference in
entries during light OFF versus ON periods was observed for control hrGFP expressing mice (n = 5), Wilcoxon matched-pairs signed rank test (p = 0.85) (data not
shown).
(H) In the absence of 593 nm light, no differences between groups were observed hrGFP(n = 10) versus eNpHR (n = 9), data presented Mann-Whitney U value,
P value: LDB, entries in light side (U = 41.5, p > 0.75), time in light side (U = 34.5, p > 0.6); OF, entries in center (U = 42.5, p > 0.85), time in center (U = 40.0, p > 0.7);
NO, entries in center (U = 35.0, p > 0.4), time in center (U = 36.0, p > 0.7).
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Figure S5. LS Crfr2a+ Neurons Send Projections to Multiple Extraseptal Targets and Make Local Inhibitory Synapses within the LS, Related
to Figure 5
(A–L) Cre-dependent ChR2-YFP AAV was stereotaxically injected into the LS ofCrfr2a-eGFPCre mice. After 4 weeks, analysis of YFP expression revealed robust
fluorescence in the LS cell bodies and processes (A and B), as well as YFP+ axons in anterior hypothalamic area (AHA, C,D), more caudal regions of medial
hypothalamus (MH, E and F), medial amygdala (MEA, G and H), periaqueductal gray (PAG, I and J), and ventral hippocampus (vHIPP, K,L). All extraseptal images
were imaged on a confocal using the identical laser settings. Numbers in parentheses indicate bregma level; boxed regions in top panels are shown at higher
magnification in bottom panels. PVN, paraventricular nucleus; VMH, ventromedial hypothalamic nucleus; opt, optic tract; CA1, CA3, fields CA1 or CA3 of
hippocampus; S, subiculum. Locations of cell nuclei and layers were determined using DAPI counterstaining (data not shown).
(M) Schematic illustrating CRACM recordings, done by patching and recording photocurrents in ChR2-YFP-negative LS neurons that are near ChR2-YFP+ fibers.
(N) Single 2 ms pulses of 473 nm light evoked strong IPSCs in 9/9 cells (B, top left); average response amplitude = 241.1 ± 54.2pA; average responses latency =
4.7 ± 0.4ms.Bottom left, 473 nm light delivered at 15 Hz (2ms pulse width) was sufficient to inhibit induced firing of postsynaptic neurons.Right, both IPSCs (top)
and IPSPs (bottom) were blocked by bath application of 100 mm picrotoxin.
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Figure S6. Photoinhibition and Photostimulation of LS Crfr2a+ Axon Terminals in AHA, Related to Figure 6
(A) Cre-dependent ArchT-GFP AAV construct.
(B–E) Stereotaxic injection of (A) into the LS of Crhr2a-eGFPCre mice yielded ArchT-GFP (green) expression in Crfr2a+ neurons (marked by Cre immunostaining,
red). Boxed area in (D) shown at higher magnification in (E).
(F) Quantification of the specificity and sensitivity of recombination, counts were performed in regions containing ArchT-GFP+ cells: ArchT+/DAPI+ = 3.0% ±
0.9%, Cre+/DAPI+ = 10.8% ± 0.2%, Cre+/ArchT+ = 76.1% ± 1.1%, ArchT+/Cre+ = 21.2% ± 6.6% (mean ± SEM). Total n = 7,253 DAPI+ cells from 2 injected mice.
(G and H) Whole cell recordings of ArchT-GFP+Crfr2a+ neurons in LS slice preparations. (H) 532 nm light drove (left) outward currents (peak = 217. ± 67.5pA;
steady state = 150.3 ± 48.7pA) and hyperpolarization (right) of large amplitude (peak =39.9 ± 16.2 mV; steady state =29.5 ± 13.3 mV). Values indicate mean ±
SEM; n = 4 ArchT-GFP+ neurons recorded.
(I) Diagram of experiment to test ArchT-GFP activity in axon terminals. Because no significant spontaneous activity of Crfr2a+ neurons was detected in slice
recordings (data not shown), we used an approach based on CRACM that enables optogenetic control over presynaptic release. (I’) Two Cre-dependent
constructs were coinjected into the LS of Crfr2a-eGFPCre mice to target expression of both ArchT-GFP and ChR2-tomato to Crfr2a+ neurons. (I’’) Postsynaptic
neurons in the AHA were then patched and photostimulation of ChR2-tomato+ArchT-GFP+ axons with 473 nm light performed either in the absence or presence
of 532 nm light. If ArchT-GFP is functional in axon terminals, the expectation is that it should be capable of suppressing ChR2-mediated IPSCs recorded from
postsynaptic neurons.
(J and K) Coexpression of ArchT-GFP (green) and ChR2-Tomato (red) in LS (J) and hypothalamus (K) in a Crfr2a-eGFPCre mouse injected in LS with Cre-
dependent AAVs encoding ArchT-GFP and ChR2-tomato.
(L) Voltage clamp recording of postsynaptic neuron in AHA from slice shown in (K). Photostimulation with a single 2 ms pulse of 473 nm light evoked IPSCs (left)
that could be reversibly blocked by illumination with 532 nm light (middle, right). Traces shown are averaged responses of 5 trials.
(M) Repetitive photoinhibition of the cell shown in (L) over a 20 min period using the same 532 nm illumination protocol as that applied in vivo (20 s light ON, 10 s
light OFF) did not produce detectable rebound activity in axon terminals following cessation of light.
(N) Inhibiting LS Crfr2a+ axons in hypothalamus during testing does not alter locomotor behavior in the open field. hrGFP(n = 12) versus ArchT (n = 10), data
presented Mann-Whitney U value, P value: (U = 42.0, p > 0.35).
(O) When light was not delivered through the guides, no significant differences in anxiety behavior were detected between groups. hrGFP(n = 12) versus ArchT
(n = 11), data presentedMann-WhitneyU value,P value: LDB, entries in light side (U = 60.0, p > 0.7), time in light side (U= 61.0, p > 0.7); OF, entries in center (5–10’)
(U = 35.0, p > 0.05), time in center (5–10’) (U = 36.0, p > 0.05); NO, entries in center (0–50) (U = 56.0, p > 0.5), time in center (0–50) (U = 55.0, p > 0.5).
(P) Stimulating LSCrfr2a+ axons in hypothalamus during testing does not alter locomotor behavior in the open field. eYFP(n = 17) versus ChR2 (n = 15), presented
as mean ± S: average velocity in open field (11.73 ± 0.2 versus 13.1 ± 0.8, p > 0.1).
Note: In the NO assay, there was a trend toward increased anxiety (decreased number of entries on lighted side) that did not reach significance (Figure 6J). This
may reflect a lower level of ChR2 present in nerve terminals (due to dilution during axonal transport). It is also possible that in the NO assay, a higher level of
stimulation is required to overcome the appetitive influence exerted by the novel object, whereas no appetitive stimuli are present in the LDB and OF assays.
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Figure S7. Evidence That LSCrfr2a+ NeuronsMonosynaptically Inhibit GABAergic Neurons in AHA andAHANeurons that Innervate the PAG,
Related to Figure 7
(A–D) LSCrfr2a+ terminals overlapwithGABAergic neurons in the AHA. Cre-dependent ChR2-YFP AAVwas injected into the LS ofCrfr2a-eGFPCremice, yielding
YFP labeling of axons (green, B,D) that are closely apposed to GABA+ cells (white, C,D) in the AHA.
(E–H) The polysynaptic anterograde tracer HSV129DTK-TT was injected into the LS ofCrfr2a-eGFPCremice, and expression of tdTomato (red) and GABA (white)
was analyzed 2 days later. This is a time point when transsynaptic transfer first becomes detectable in the hypothalamus and many labeled cells are thus likely to
be monosynaptic targets (labeling in the PVN is not detected until 3 days postinjection). Consistent with the ChR2-YFP tracing, we observed tdT+GABA+ cells
(F-H), suggesting that GABAergic neurons in the AHA are a target of LS Crfr2a+ neurons.
(I–L) Combined CRACMand retrograde tracing demonstrate that LSCrfr2a+ neuronsmonosynaptically inhibit AHA neurons that project to the PAG. (I) Schematic
of experiment, in which Cre-dependent ChR2-YFP was injected into the LS of Crfr2a-eGFPCre mice and Alexa647-conjugated CTB was injected into the PAG.
(J) This yielded strong CTB labeling at the site of injection (PAG) as well as in scattered backlabeled neurons throughout the AHA. (K,L) Single 2 ms pulses of
473 nm light evoked strong IPSCs in 4/5 CTB+ cells in the AHA; average response amplitude = 74.7 ± 25.8pA; average responses latency = 4.1 ± 0.4 ms,
consistent with monosynaptic connectivity.
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